Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6272602 | 0.77 | EDNRA (0.37) | — | |
| SCHEMBL8890229 | 0.76 | POLB (0.34) | — | |
| SCHEMBL6233907 | 0.75 | HTR2A (0.43) | HTR2A | |
| SCHEMBL31046607 | 0.75 | HTR2A (0.43) | HTR2A | |
| SCHEMBL3773580 | 0.74 | HTR2A (0.30) | HTR2A | |
| SCHEMBL291732 | 0.74 | BRD4 (0.32) | HTR2A | |
| SCHEMBL3862739 | 0.74 | MAOA (0.32) | HTR2A | |
| SCHEMBL3048014 | 0.74 | HTR2A (0.30) | HTR2A | |
| SCHEMBL1547704 | 0.74 | HTR2A (0.30) | HTR2A | |
| SCHEMBL3858050 | 0.74 | HTR2A (0.30) | HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2419496-A1 | ASSOCIATIVE POLYMERS FOR MIST-CONTROL | California Institute of Technology (US) | 2012-02-22 | — | — | EP | claimed |
| WO-2010121270-A1 | ASSOCIATIVE POLYMERS FOR MIST-CONTROL | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2010-10-21 | — | — | WO | claimed |
| EP-2132211-A2 | 4-CYANOPHENYLAMINO-SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INHIBITORS | Ardea Biosciences, Inc. (US) | 2009-12-16 | — | — | EP | claimed |
| EP-1703797-A4 | TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2009-01-14 | — | — | EP | claimed |
| EP-1877411-A4 | DIARYL-PURINE, AZAPURINES AND -DEAZAPURINES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF HIV | ARDEA BIOSCIENCES INC (US) | 2008-10-22 | — | — | EP | claimed |
| WO-2008058285-A2 | 4-CYANOPHENYLAMINO-SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INHIBITORS | ARDEA BIOSCIENCES, INC. (US) | 2008-05-15 | — | — | WO | claimed |
| EP-1877411-A2 | DIARYL-PURINE, AZAPURINES AND -DEAZAPURINES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF HIV | Ardea Biosciences, Inc. (US) | 2008-01-16 | — | — | EP | claimed |
| EP-1534273-A4 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR AND METHOD | BRISTOL MYERS SQUIBB CO (US) | 2007-08-22 | — | — | EP | claimed |
| WO-2006122003-A2 | DIARYL-PURINE, AZAPURINES AND -DEAZAPURINES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF HIV | ARDEA BIOSCIENCES, INC. (US) | 2006-11-16 | — | — | WO | claimed |
| EP-1703797-A2 | TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF | Bristol-Myers Squibb Company (US) | 2006-09-27 | — | — | EP | claimed |
| WO-2005072132-A2 | TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-08-11 | — | — | WO | claimed |
| EP-1534273-A2 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR AND METHOD | Bristol-Myers Squibb Company (US) | 2005-06-01 | — | — | EP | claimed |
| WO-2004009017-A2 | MODULATORS OF THE GLUCOCORTICOID RECEPTOR AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-01-29 | — | — | WO | claimed |
| EP-2419496-A1 | ASSOCIATIVE POLYMERS FOR MIST-CONTROL | California Institute of Technology (US) | 2012-02-22 | — | — | EP | disclosed |
| WO-2010121270-A1 | ASSOCIATIVE POLYMERS FOR MIST-CONTROL | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2010-10-21 | — | — | WO | disclosed |
| EP-1703797-A4 | TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2009-01-14 | — | — | EP | disclosed |
| WO-2000034249-A1 | PROCESS FOR PREPARING PYRIDAZIN-3-ON DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-06-15 | — | — | WO | disclosed |
| EP-0833818-A1 | CB 2? RECEPTOR AGONIST COMPOUNDS | SANOFI (FR) | 1998-04-08 | — | — | EP | disclosed |
| EP-0142835-A2 | Bis-aminopyridinium salts and their use as phase transfer catalysts for aromatic ether imide preparation | GENERAL ELECTRIC COMPANY (US) | 1985-05-29 | — | — | EP | disclosed |
| EP-0141692-A1 | Bis-quaternary salts as phase transfer catalysts for aromatic ether imide preparation | GENERAL ELECTRIC COMPANY (US) | 1985-05-15 | — | — | EP | disclosed |